Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A0A3S7X6S0
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 7 |
GO:0003723 | RNA binding | 4 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 66 | 68 | PF00675 | 0.721 |
CLV_PCSK_KEX2_1 | 110 | 112 | PF00082 | 0.346 |
CLV_PCSK_KEX2_1 | 66 | 68 | PF00082 | 0.735 |
CLV_PCSK_PC1ET2_1 | 110 | 112 | PF00082 | 0.346 |
CLV_PCSK_SKI1_1 | 179 | 183 | PF00082 | 0.495 |
CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.330 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.666 |
DEG_SCF_FBW7_1 | 194 | 201 | PF00400 | 0.676 |
DEG_SCF_FBW7_1 | 54 | 61 | PF00400 | 0.772 |
DOC_CYCLIN_yCln2_LP_2 | 14 | 17 | PF00134 | 0.677 |
DOC_MAPK_gen_1 | 69 | 78 | PF00069 | 0.506 |
DOC_PP2B_LxvP_1 | 14 | 17 | PF13499 | 0.677 |
DOC_USP7_MATH_1 | 145 | 149 | PF00917 | 0.464 |
DOC_USP7_MATH_1 | 192 | 196 | PF00917 | 0.547 |
DOC_USP7_MATH_1 | 198 | 202 | PF00917 | 0.377 |
DOC_WW_Pin1_4 | 194 | 199 | PF00397 | 0.647 |
DOC_WW_Pin1_4 | 54 | 59 | PF00397 | 0.768 |
LIG_APCC_ABBA_1 | 182 | 187 | PF00400 | 0.534 |
LIG_BRCT_BRCA1_1 | 129 | 133 | PF00533 | 0.509 |
LIG_FHA_1 | 168 | 174 | PF00498 | 0.492 |
LIG_FHA_1 | 197 | 203 | PF00498 | 0.603 |
LIG_FHA_2 | 136 | 142 | PF00498 | 0.478 |
LIG_FHA_2 | 84 | 90 | PF00498 | 0.522 |
LIG_LIR_Nem_3 | 130 | 136 | PF02991 | 0.480 |
LIG_LIR_Nem_3 | 92 | 97 | PF02991 | 0.544 |
LIG_SH2_NCK_1 | 60 | 64 | PF00017 | 0.670 |
LIG_SH2_STAP1 | 204 | 208 | PF00017 | 0.633 |
LIG_SH2_STAT3 | 38 | 41 | PF00017 | 0.642 |
LIG_SH2_STAT5 | 153 | 156 | PF00017 | 0.543 |
LIG_SH2_STAT5 | 166 | 169 | PF00017 | 0.501 |
LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.744 |
LIG_SH3_3 | 10 | 16 | PF00018 | 0.668 |
LIG_SH3_3 | 131 | 137 | PF00018 | 0.565 |
LIG_SH3_3 | 186 | 192 | PF00018 | 0.562 |
LIG_SH3_3 | 59 | 65 | PF00018 | 0.704 |
LIG_SUMO_SIM_anti_2 | 143 | 148 | PF11976 | 0.480 |
LIG_SUMO_SIM_par_1 | 102 | 109 | PF11976 | 0.546 |
LIG_WW_3 | 63 | 67 | PF00397 | 0.769 |
MOD_CK2_1 | 135 | 141 | PF00069 | 0.480 |
MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.431 |
MOD_GlcNHglycan | 20 | 23 | PF01048 | 0.637 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.445 |
MOD_GSK3_1 | 167 | 174 | PF00069 | 0.489 |
MOD_GSK3_1 | 192 | 199 | PF00069 | 0.515 |
MOD_GSK3_1 | 54 | 61 | PF00069 | 0.737 |
MOD_NEK2_1 | 106 | 111 | PF00069 | 0.546 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.741 |
MOD_NEK2_1 | 49 | 54 | PF00069 | 0.543 |
MOD_NEK2_2 | 145 | 150 | PF00069 | 0.476 |
MOD_PIKK_1 | 116 | 122 | PF00454 | 0.630 |
MOD_Plk_4 | 15 | 21 | PF00069 | 0.702 |
MOD_ProDKin_1 | 194 | 200 | PF00069 | 0.656 |
MOD_ProDKin_1 | 54 | 60 | PF00069 | 0.771 |
TRG_ENDOCYTIC_2 | 97 | 100 | PF00928 | 0.546 |
TRG_ER_diArg_1 | 65 | 67 | PF00400 | 0.740 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P505 | Leptomonas seymouri | 77% | 100% |
A4HLK6 | Leishmania braziliensis | 84% | 100% |
A4I917 | Leishmania infantum | 100% | 100% |
E9B3Y2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
Q4Q442 | Leishmania major | 98% | 100% |